Search Knowledge Base

21 results for "heparin-low-molecular-weight"

Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair pubmed_article
Evidence Source 2025 PMID: 39868562
Perioperative Management of Vitamin K Antagonists and Direct Oral Anticoagulants: A Systematic Review and Meta-analysis pubmed_article
Evidence Source 2023 PMID: 36462533
Regional Citrate Anticoagulation or Heparin Anticoagulation for Renal Replacement Therapy in Patients With Liver Failure: A Systematic Review and Meta-Analysis pubmed_article
Evidence Source 2023 PMID: 37186766
Safety and efficacy of apixaban versus low-molecular weight heparin or vitamin-K antagonists for venous thromboembolism treatment in patients with severe renal failure: A systematic review and meta-analysis pubmed_article
Evidence Source 2023 PMID: 37419006
Safety and efficacy of Direct Oral Anticoagulants in cerebral venous thrombosis: A meta-analysis pubmed_article
Evidence Source 2022 PMID: 34287841
Network meta-analysis of anticoagulation strategies for venous thromboembolism in patients with cancer pubmed_article
Evidence Source 2021 PMID: 32458316
Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents pubmed_article
Evidence Source 2021 PMID: 34582035
Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation pubmed_article
Evidence Source 2021 PMID: 34622445
Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity pubmed_article
Evidence Source 2020 PMID: 32692430
Vitamin K antagonists versus low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism pubmed_article
Evidence Source 2017 PMID: 28737834
Pentasaccharides for the treatment of deep vein thrombosis pubmed_article
Evidence Source 2017 PMID: 29199766
Systematic review with meta-analysis: the risk of major gastrointestinal bleeding with non-vitamin K antagonist oral anticoagulants pubmed_article
Evidence Source 2015 PMID: 26434935
Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity pubmed_article
Evidence Source 2013 PMID: 24343728
Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism pubmed_article
Evidence Source 2012 PMID: 23076894
Anticoagulation for patients with cancer and central venous catheters pubmed_article
Evidence Source 2011 PMID: 21328283
Anticoagulation for patients with cancer and central venous catheters pubmed_article
Evidence Source 2011 PMID: 21491394
Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer pubmed_article
Evidence Source 2011 PMID: 21678361
Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer pubmed_article
Evidence Source 2008 PMID: 18425959
Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters pubmed_article
Evidence Source 2007 PMID: 17636845
Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism pubmed_article
Evidence Source 2002 PMID: 11869618
Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism pubmed_article
Evidence Source 2000 PMID: 11034739

Evidence Search Results semantic · quality-ranked

Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair meta_analysis pubmed_article
Quality: 77 2025 PMID: 39868562 DOI: 10.1002/14651858.CD011762.pub2
Impact of conventional lipid-lowering therapy on circulating levels of proprotein convertase subtilisin/kexin type 9: A systematic review and meta-analysis of randomised controlled trials meta_analysis pubmed_article
Quality: 64 2026 PMID: 41656962 DOI: 10.1111/dom.70475
Efficacy and Safety of Direct Oral Anticoagulants in Cerebral Venous Thrombosis: Meta-Analysis of Randomized Clinical Trials meta_analysis pubmed_article
Quality: 62 2024 PMID: 38772568 DOI: 10.1177/10760296241256360
Effect of low-ratio n-6/n-3 PUFA on blood lipid level: a meta-analysis meta_analysis pubmed_article
Quality: 63 2021 PMID: 33123975 DOI: 10.1007/s42000-020-00248-0
Vitamin K antagonists versus low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism meta_analysis pubmed_article
Quality: 71 2017 PMID: 28737834 DOI: 10.1002/14651858.CD002001.pub3
Direct Oral Anticoagulants Versus Vitamin K Antagonists in Cerebral Venous Thrombosis: A Systematic Review and Meta-Analysis of 4,929 Patients meta_analysis pubmed_article
Quality: 57 2025 PMID: 41358859 DOI: 10.1177/10760296251405417
Safety and efficacy of apixaban versus low-molecular weight heparin or vitamin-K antagonists for venous thromboembolism treatment in patients with severe renal failure: A systematic review and meta-analysis meta_analysis pubmed_article
Quality: 55 2023 PMID: 37419006 DOI: 10.1016/j.thromres.2023.06.027
Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer meta_analysis pubmed_article
Quality: 75 2014 PMID: 25004410 DOI: 10.1002/14651858.CD006650.pub4
Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension meta_analysis cochrane_review
Quality: 74 2016 PMID: 26935713 DOI: 10.1002/14651858.CD007435.pub3
Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis systematic_review pubmed_article
Quality: 58 2015 PMID: 26716830 DOI: 10.1371/journal.pone.0144856

View full evidence search →